Biolaxy Secures IND Approval For Oral Insulin
SHANGHAI, November 24 /PRNewswire/ -- Shanghai Biolaxy announced the Chinese State Food Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin…